According to FutureWise analysis, the Artificial Intelligence in Drug Discovery Market is expected to grow with a CAGR of 45.9% over the forecast period 2023-2031, and reach a market value of US$ 18 billion by 2031.
Artificial Intelligence (AI) has revolutionized the landscape of drug discovery, offering innovative approaches that expedite the identification and development of potential pharmaceutical compounds. In this context, AI refers to the utilization of computational algorithms and machine learning models to analyze complex biological data, predict molecular interactions, and streamline the drug discovery process. By assimilating vast datasets from various sources, including genetic information, chemical structures, and biological pathways, AI enables researchers to identify promising drug candidates with higher efficiency and accuracy. This technology empowers scientists to explore expansive chemical spaces, forecast potential drug-target interactions, and optimize molecular structures, leading to the accelerated development of new medications.
FutureWise Market Research has published a report that provides an insightful analysis of Artificial Intelligence in Drug Discovery Market trends affecting overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Artificial-Intelligence-in/5833
Artificial Intelligence in Drug Discovery Market Segmentation:
By Offering
• Software
• Services

By Technology
• Machine Learning
o Deep Learning
o Supervised Learning
o Reinforcement Learning
o Unsupervised Learning
o Other Machine Learning Technologies
• Others Technologies

By Application
• Immuno-oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Metabolic Diseases
• Other Applications

By End User
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Research Centers and Academic and Government Institutes

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in the Artificial Intelligence in Drug Discovery Market:

• Microsoft Corporation
• NVIDIA Corporation
• IBM Corporation
• Google (A Subsidiary of Alphabet Inc.)
• Atomwise Inc.
• Deep Genomics
• Cloud Pharmaceuticals, Inc.
• Insilico Medicine
• Benevolentai
• Exscientia
• Cyclica
• Bioage
• Numerate
• Numedii Inc.
• Envisagenics
• TwoXAR
• OWKIN Inc.
• Verge Genomics
• XtalPi
• Berg LLC.

Buy now the latest version of this report:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=5833&license=single

**Objectives of this Study: **
1. To provide a comprehensive analysis of the Artificial Intelligence in Drug Discovery Market By Offering, By Technology, By Application, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Related market:
Some of the other related markets that you might be interested in are listed as below:
Artificial Intelligence in Drug Screening Market

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com